Enhanced Nitric Oxide Synthesis Reverses Salt-Induced Alterations in Blood Flow and Cgmp Levels

References

• Lüscher T F, Boulaager C M, Cohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992; 19: 117–130
   PubMed Web of Science ®Google Scholar
• Nelson M T, Quayle J M. Physiological roles and properties of potassium channels in arterial smooth muscle. Amer. J. Physiol 1995; 268: C799–C822
   PubMed Web of Science ®Google Scholar
• Lipp P, Niggli E. A hierachical concept of cellular and subcellular Ca2+-signalling. Progr. Biophys. mol. Biol 1996; 65: 265–296
   PubMed Web of Science ®Google Scholar
• Bayorh M A, McGee L, Feuersteiri G. Acute and chronic effects of eicosapentaenoic acid (EPA) on the cardiovascular system. Res. Commun. Chem. Pathol. Pharmacol 1989; 66: 355–374
   PubMedGoogle Scholar
• Bayorh M A, Williams E F, Ogbolu Walker E G, E C, Manor E L, Brown L G, Chenault V M. Effects of MaxEPA on salt-induced hypertension: Relationship to [3H]nitrobenzylthioinosine binding sites. Clin. Exp. Hypertension 1996; 18: 37–49
   PubMed Web of Science ®Google Scholar
• Burr M. Fish food fish oil and cardiovascular disease. Clin. Exper. Hypertension 1992; A14: 181–192
   Google Scholar
• Hoffman P. Cardiovascular actions of dietary polyunsaturated fatty acids and related mechanisms: a state of the art review. Prostagl. Leukotr. Med 1986; 21: 113–147
   PubMedGoogle Scholar
• Tobian L. Salt and hypertension: Lessons from animal models that relate to human hypertension. Hypertension 1991; 17((Suppl. I))I55–I60
   Google Scholar
• Dahl L K, Knudsen K D, Heine M, Leitl G. Effects of chronic excess salt ingestion. Genetic influence on the development of salt hypertension in parabiotic rats: evidence for a humoral factor. J. Exp. Med 1967; 126: 687–699
   Google Scholar
• Dahl L K, Knudsen K D, Iwai J. Humoral transmission of hypertension: Evidence from parabiosis. Circ. Res 1969, (Suppl. 1): 24–25, 21–33
   Google Scholar
• Folkow B, Ely D L. Editorial Review. Dietary sodium effects on cardiovascular and sympathetic neuroeffector function as studied in various rat models. J. Hypertension 1987; 5: 383–395
   Google Scholar
• Mark A L. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension 1991; 17((Suppl. I))I86–I90
   PubMedGoogle Scholar
• Chen P Y, Sanders P W. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest 1991; 88: 1559–1567
   PubMed Web of Science ®Google Scholar
• Luscher T F, Raij L, VanHoutte P M. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl strain rats. Hypertension 1987; 9: 157–163
   PubMed Web of Science ®Google Scholar
• Kong J.-Q, Taylor D A, Fleming W W, Kotchen T A. Specific supersensitivity of the mesenteric vascular bed of Dahl salt-sensitive rats. Hypertension 1991; 17: 349–356
   PubMed Web of Science ®Google Scholar
• Akiba Y, Yamaguchi N, Amano H, Fujii T, Fujimoto K, Suzuki T, Kawashima K. Role of nitric oxide in the control of blood pressure in young and adult spontaneously hypertensive rats. Clin. Exper. Pharmacol. Physiol 1995; 22(Suppl. 1)S142–S143
   Google Scholar
• Rees D D, Palmer R M. J, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Nat'l. Acad. Sci. USA 1989; 86: 3375–3378
   PubMed Web of Science ®Google Scholar
• Chu T C, Socci R R, Potter D E. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: Role of cGMP. Pharmacol 1997; 55: 211–216
   PubMed Web of Science ®Google Scholar
• Merkel L. Zaprinast: A cGMP-selective phosphodiesterase inhibitor. Cardiovasc. Drug Rev 1993; 11: 501–515
   Google Scholar
• Schmieder R E, Rüddel H, Schächinger H, Bruns J, Schulte W. Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behavioral Medicine 1993; 19: 5–12
   PubMed Web of Science ®Google Scholar
• Saavendra J M, McCarty R, Fernandez-Pardal J, Giucheney P, Weise V, Iwai J. Proceedings of Fourth International Symposium on Rats with Spontaneous Hypertension. Heidelberg 1981; 28
   Google Scholar
• Takeshita A, Mark A L, Brody M J. Prevention of salt-induced hypertension in the Dahl strain by 6-hydroxydopamine. Amer. J. Physiol 1979; 236: H48–H52
   PubMed Web of Science ®Google Scholar
• Campese V M, Romoff M S, Levitan J, Saglikes Y, Fredier R, Massry S G. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Intl 1982; 21: 371–378
   PubMed Web of Science ®Google Scholar
• Deng A Y, Rapp J P. Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in Dahl salt-sensitive rats. J. Clin. Invest 1995; 95: 2170–2177
   PubMed Web of Science ®Google Scholar
• Ferrario C M, Tramposch A, Kawano Y, Brosnihan K B. Sodium balance and the reflex regulation of baroreceptor function. Circulation 1987; 75((Suppl. I))I141–I148
   PubMedGoogle Scholar
• Simchon S, Manger W M, Carlin R D, Peeters L L, Rodriguez J R, Batista D, Brown T, Merchant N B, Jan K M, Brinberg D E, Chien S. Salt-induced hypertension in Dahl salt-sensitive rats: hemodynamics and renal responses. Hypertension 1989; 13: 612–621
   PubMed Web of Science ®Google Scholar
• Simchon S, Manger W M, Brown T W. Dual hemodynamic mechanisms for salt-induced hypertension in salt-sensitive Dahl rats. Hypertension 1991; 17: 1063–1071
   PubMed Web of Science ®Google Scholar
• Kumagai K, Suzuki H, Ichikawa M, Jimbo M, Murakami M, Ryuzaki M, Saruta T. Nitric oxide increases renal blood flow by interacting with the sympathetic nervous system. Hypertension 1994; 24: 220–226
   PubMed Web of Science ®Google Scholar
• Aisaka K, Gross S S, Griffith O W, Levi R. NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate the blood pressure in vivo?. Biochem. Biophys. Res. Commun 1989; 160: 881–886
   PubMed Web of Science ®Google Scholar
• Calver A, Collier J, Vallance P. L-arginine-induced hypotension. Lancet 1990; 336: 1016–1017
   PubMedGoogle Scholar
• Mimran A, Ribstein J, DuCailar G. Contrasting effect of antihypertensive treatment on the renal response to l-arginine. Hypertension 1995; 26: 937–941
   PubMed Web of Science ®Google Scholar
• Dundore R L, Clas D M, Wheeler L T, Habeeb P G, Bode D C, Buchholz R A, Silver P J, Pagani E D. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats. Eur. J. Pharmacol 1993; 249: 293–297
   PubMed Web of Science ®Google Scholar
• Paul R V, Wackym P S, Warnock D G. Decreased cyclic GMP response to ANP in mesanglial cells from salt-sensitive (SS-JR) compared to salt-resistant (SR-JR) rats. Hypertension 1993; 22: 431, Abstract
   Web of Science ®Google Scholar
• Ferri C, Bellini C, Piccoli A, Carlomagno A, Bonavita M S, Santucci A, Balsano F. Enhanced blood pressure response in cyclooxygenase inhibition in salt-sensitive human essential hypertension. Hypertension 1993; 21: 875–881
   PubMed Web of Science ®Google Scholar